FCER2 and intrahepatic cholangiocarcinoma: ICC maintained these categories and formally added BCL2-rearrangement negative, CD23 + follicle center lymphoma (largely corresponding to the predominantly diffuse follicle center lymphomas noted in WHO-HAEM4R) and testicular follicular lymphoma as distinct entities.(2).